SNAP25 is a potential prognostic biomarker for prostate cancer.

Di L, Gu M, Wu Y, Liu G, Zhang L, Li Y, Zhang W

DOI: 10.1186/s12935-022-02558-2
Published: 2022 Apr 7
Container: Cancer cell international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12935-022-02558-2,
  title = {SNAP25 is a potential prognostic biomarker for prostate cancer.},
  author = {Di L and Gu M and Wu Y and Liu G and Zhang L and Li Y and Zhang W},
  year = {2022},
  journal = {Cancer cell international},
  doi = {10.1186/s12935-022-02558-2},
  url = {https://doi.org/10.1186/s12935-022-02558-2}
}

RIS

TY  - JOUR
TI  - SNAP25 is a potential prognostic biomarker for prostate cancer.
AU  - Di L
AU  - Gu M
AU  - Wu Y
AU  - Liu G
AU  - Zhang L
AU  - Li Y
AU  - Zhang W
PY  - 2022
JO  - Cancer cell international
DO  - 10.1186/s12935-022-02558-2
UR  - https://doi.org/10.1186/s12935-022-02558-2
ER  -

APA

L, D., M, G., Y, W., G, L., L, Z., Y, L., & W, Z. (2022). SNAP25 is a potential prognostic biomarker for prostate cancer.. Cancer cell international. https://doi.org/10.1186/s12935-022-02558-2

Source records

pubmed · retrieved 2026-09-27T14:34:48.524Z